Gastrointestinal bleeding complicating antiplatelet treatment after percutaneous coronary intervention(PCI)
Phase 4
- Conditions
- patients for indicated antiplatelet treatment after percutaneous coronary intervention(PCI)
- Registration Number
- JPRN-UMIN000001610
- Lead Sponsor
- Graduate School of Medicine Science, Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
Not provided
Exclusion Criteria
Patients were excluded if patients had been malignant disease, previous upper abdominal surgery, neuropsychiatric disorder, organic brain damage, severe hepato-renal disorder, symptoms suggesting or were pregnant.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The current study attempted to compare the efficacy of rabeprazole with omeprazole in patients indicated for antiplatelet treatment after PCI
- Secondary Outcome Measures
Name Time Method upper gastrointestinal bleeding. Gastrointestinal symptom(Gastrointesitinal Symptom Rating Scale).